Table of Contents Table of Contents
Previous Page  30 / 56 Next Page
Information
Show Menu
Previous Page 30 / 56 Next Page
Page Background

30

Scientific programme

Friday, 21 April 2017

P-17-007 Treatment patterns, resource utilisation,

and healthcare costs associated with the

use of atypical antipsychotics or guan-

facine extended release in stimulant-

treated children and adolescents with

ADHD in Quebec

J. van Stralen, Canada

J. Lachaine, L. Ben Amor, J. Burns

P-17-008 Long-term safety and efficacy of guan-

facine extended release in children and

adolescents with ADHD

J. Newcorn, USA

J. A. Ramos Quiroga, B. Dirks, J. Gu, M. Huss

P-17-009 Clinical investigation of children with

ADHD treated with atomoxetine oral

solution

T. Ichiyama, Japan

N. Ishikawa, H. Matsufuji, H. Isumi, Y. Sugio

P-17-010 Increase in prescription rates of ADHD

medication from pharmacy data within

an urban child and adolescent specialist

clinic in London. There was a decline in

the use of newer preparations

D. Perera, United Kingdom

O. Moghraby, M. Akhunbay-Fudge, O.

Moghraby

P-18

Guided Poster Tour

14:30–16:00

Exhibit Hall A

Treatment adults

Chair:

W. Retz, Germany

P-18-001 Characteristics of a freelance community

sample with ADHD and their views on

online therapy

M. Bosman, USA

J. Swart

P-18-002 Stressed young males with ADHD:

Transition to adult healthcare in a natu-

ralistic setting

J. Rademacher, Germany

S. Dechering, S. Michalek

P-18-003 Clinical characteristics of an adult ADHD

with comorbid anxiety disorder sample

M. Van Ameringen, Canada

B. Patterson, W. Simpson, J. Turna, K. Pullia

P-18-004 Comparing knowledge acquisition and

practice change between ADHD and

other health conditions among primary

care clinicians

G. Mattingly, USA

P-18-005 Comparison of knowledge uptake and

active learning between ADHD and

other health conditions among primary

care clinicians receiving simulcast con-

tinuing medical education

G. Mattingly, USA

P-18-006 Cannabinoid therapy in a case of adult

ADHD

M. Koelle, Germany

K. Heckel, G. Groen

P-18-007 Health-related quality of life and burden

of illness at assessment in adult patients

with Attention-Deficit/Hyperactivity

Disorder: A chart review

Y. Ginsberg, Sweden

M. Di Schiena, A.-C. Fredman, E. Medin, J.

K. Söderling, E. Ahnemark

P-19

Guided Poster Tour

14:30–16:00

Exhibit Hall A

Quality of life /Caregiver burden I

Chair:

D. Silva, Australia

P-19-004 Parents´ participation in taking care of

hospitalised children (ADHD): A concept

analysis with hybrid model

M. Salsali, Iran

P. Vasli, M. Armeen

P-19-005 The positive aspects of ADHD: A small-

scale qualitative investigation about the

views of adult males with ADHD

J. Sedgwick, United Kingdom

A. Merwood, P. Asherson, F. Mowlem

P-19-006 Impact on the family unit of early morn-

ing functional impairments in stimulant-

treated children and adolescents with

Attention-Deficit/Hyperactivity Disorder

R. Schachar, Canada

S. Faraone, R. Barkley, R. Nullmeier, F. Sallee